Tag: Reblozyl

Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…

(CercleFinance.com) – Bristol Myers Squibb has received a positive CHMP opinion for Reblozyl (luspatercept) in adult patients with anemia-associated non-transfusion-dependent beta-thalassemia (ATN). The recommendation will now be considered by the…